Appropriate use is determined individually by a licensed medical provider based on your health profile, and it requires a prescription and clinical oversight
Possible side effects include: Injection site pain, redness, or bruising Unwanted facial or body hair growth Copper imbalance, which may cause headaches, nausea, or fatigue Flushing or histamine-type reactions in sensitive individuals Injectable copper peptides may not be appropriate for individuals with liver conditions, disorders of copper metabolism (such as Wilsons disease), or significant inflammatory sensitivity
Its large genome can accommodate insertions over 30 kb or deletions of multiple virulence genes without compromising lytic replication in tumor cells
A substance must meet one of the following criteria to be used as an active ingredient by a 503A pharmacy: Have an applicable United States Pharmacopeia (USP) or National Formulary (NF) monograph Are a component of an FDA-approved drug Are on the FDAs 503A Bulk Substances List (sometimes referred to as the positive list) According to the Drug Quality and Security Act, ingredients only need to comply with one of the criteria above, and those that do not meet any of them cannot be used as active ingredients for human compounding by 503A pharmacies